Question

Impact of early initiated everolimus on the recurrence of hepatocellular carcinoma after liver transplantation

Answer 1

initiated everolimus on tumor recurrence after liver transplantation. ... CONCLUSION: Everolimus may not be universally prescribed to prevent tumor recurrence in liver transplant patients with hepatocellular carcinoma.

Answer 2

Explanation:

Carcinoma is a type of cancer that starts in cells that make up the skin or the tissue lining organs, such as the liver or kidneys. Like other types of cancer, carcinomas are abnormal cells that divide without control. They are able to spread to other parts of the body, but don't always.